These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29618723)

  • 21. [Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice].
    Lan J; Lu S; Deng Y; Wen B; Chen H; Wang W; Tan W
    Bing Du Xue Bao; 2016 Jan; 32(1):77-81. PubMed ID: 27295887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
    Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
    Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
    Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
    J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.
    Choi J; Kim MG; Oh YK; Kim YB
    Expert Opin Ther Pat; 2017 Jun; 27(6):721-731. PubMed ID: 28121202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of candidate vaccine approaches for MERS-CoV.
    Wang L; Shi W; Joyce MG; Modjarrad K; Zhang Y; Leung K; Lees CR; Zhou T; Yassine HM; Kanekiyo M; Yang ZY; Chen X; Becker MM; Freeman M; Vogel L; Johnson JC; Olinger G; Todd JP; Bagci U; Solomon J; Mollura DJ; Hensley L; Jahrling P; Denison MR; Rao SS; Subbarao K; Kwong PD; Mascola JR; Kong WP; Graham BS
    Nat Commun; 2015 Jul; 6():7712. PubMed ID: 26218507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
    Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
    Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.
    Li K; Li Z; Wohlford-Lenane C; Meyerholz DK; Channappanavar R; An D; Perlman S; McCray PB; He B
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
    Volz A; Kupke A; Song F; Jany S; Fux R; Shams-Eldin H; Schmidt J; Becker C; Eickmann M; Becker S; Sutter G
    J Virol; 2015 Aug; 89(16):8651-6. PubMed ID: 26018172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
    Veit S; Jany S; Fux R; Sutter G; Volz A
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
    Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
    PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice.
    Wang C; Zheng X; Gai W; Wong G; Wang H; Jin H; Feng N; Zhao Y; Zhang W; Li N; Zhao G; Li J; Yan J; Gao Y; Hu G; Yang S; Xia X
    Antiviral Res; 2017 Apr; 140():55-61. PubMed ID: 28040513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model.
    Bodmer BS; Fiedler AH; Hanauer JRH; Prüfer S; Mühlebach MD
    Virology; 2018 Aug; 521():99-107. PubMed ID: 29902727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.
    Lan J; Deng Y; Chen H; Lu G; Wang W; Guo X; Lu Z; Gao GF; Tan W
    PLoS One; 2014; 9(11):e112602. PubMed ID: 25405618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus.
    Lan J; Deng Y; Song J; Huang B; Wang W; Tan W
    Virol Sin; 2018 Oct; 33(5):453-455. PubMed ID: 30374826
    [No Abstract]   [Full Text] [Related]  

  • 36. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.
    Haagmans BL; van den Brand JM; Raj VS; Volz A; Wohlsein P; Smits SL; Schipper D; Bestebroer TM; Okba N; Fux R; Bensaid A; Solanes Foz D; Kuiken T; Baumgärtner W; Segalés J; Sutter G; Osterhaus AD
    Science; 2016 Jan; 351(6268):77-81. PubMed ID: 26678878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection.
    Jia W; Channappanavar R; Zhang C; Li M; Zhou H; Zhang S; Zhou P; Xu J; Shan S; Shi X; Wang X; Zhao J; Zhou D; Perlman S; Zhang L
    Emerg Microbes Infect; 2019; 8(1):760-772. PubMed ID: 31130102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospects for a MERS-CoV spike vaccine.
    Zhou Y; Jiang S; Du L
    Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
    Sekimukai H; Iwata-Yoshikawa N; Fukushi S; Tani H; Kataoka M; Suzuki T; Hasegawa H; Niikura K; Arai K; Nagata N
    Microbiol Immunol; 2020 Jan; 64(1):33-51. PubMed ID: 31692019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice.
    Li E; Chi H; Huang P; Yan F; Zhang Y; Liu C; Wang Z; Li G; Zhang S; Mo R; Jin H; Wang H; Feng N; Wang J; Bi Y; Wang T; Sun W; Gao Y; Zhao Y; Yang S; Xia X
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31470645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.